Liver Cancer clinical trials in Hawaii

3 actively recruiting liver cancer trials at 1 site across Hawaii.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 1, Phase 2 Recruiting Industry

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1303/BNT323 in subjects with advanced solid tumors that express HER2.

Sponsor: DualityBio Inc.

NCT ID: NCT05150691

Sites in Hawaii:

Kapi'olani Medical Center for Women and Children — Honolulu, Hawaii

View on ClinicalTrials.gov →

Phase 2 Recruiting Academic/Other

Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma

This prospective clinical trial will evaluate PET/CT and genomic liquid biopsy based biomarkers as predictors of clinical therapeutic response to immune-checkpoint inhibitor (ICI) therapy for patients with inoperable hepatocellular carcino…

Sponsor: Queen's Medical Center

NCT ID: NCT04965454

Sites in Hawaii:

The Queen's Medical Center — Honolulu, Hawaii

View on ClinicalTrials.gov →

NA Recruiting NIH

The Vanguard Study: Testing a New Way to Screen for Cancer

The Vanguard Study is a feasibility study to explore several aspects of evaluating multi-cancer detection (MCD) tests in a future definitive randomized controlled trial. An MCD test measures markers in the blood in order to screen for mult…

Sponsor: National Cancer Institute (NCI)

NCT ID: NCT06995898

Sites in Hawaii:

Kaiser Permanente Moanalua Medical Center — Honolulu, Hawaii

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20